Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-20
Paul D. Drew profile photo

Paul D. Drew

Federal Grant PI High Impact

Professor and Chair

Also affiliated: National Institutes of Health (1994–1997); National Institute of Neurological Disorders and Stroke (1993–1997); Arkansas Department of Health (2009); University of Maryland, College Park (1986–1990)

Faculty Researcher

Neurobiology & Developmental Science, College of Medicine

39 h-index 86 pubs 4,733 cited

  • Animals
  • Mice
  • Microglia
  • Humans
  • Mice, Inbred C57BL
  • Ethanol
  • Cells, Cultured
  • Cytokines
  • Nitric Oxide
  • Fetal Alcohol Spectrum Disorders
  • Female
  • Multiple Sclerosis
  • RNA, Messenger
  • Transcription Factors
  • Gene Expression Regulation

Biography and Research Information

OverviewAI-generated summary

Paul D. Drew's research program investigates the impact of ethanol exposure on neurodevelopment and neuroinflammation, with a particular focus on Fetal Alcohol Spectrum Disorders (FASD). His work utilizes animal models, specifically mice, to study the molecular and cellular mechanisms underlying these effects. Drew's laboratory has explored how ethanol influences the immune cells of the brain, such as microglia, and their role in neuroinflammatory processes relevant to FASD.

His funded research projects examine the dynamic interactions between the neuroimmune system and the onset and progression of FASD, the role of oligodendrocyte-lineage cells in FASD, and how neuroinflammation contributes to cognitive deficits associated with prenatal alcohol exposure. Drew has published extensively on these topics, with his work detailing ethanol's effects on cerebellar and hippocampal neuroinflammation, myelination, and gene expression in developing mouse models. His scholarship metrics include an h-index of 39 and over 4,700 citations across 86 publications.

Drew leads a research group at the University of Arkansas for Medical Sciences, where he holds the position of Professor and Chair of Neurobiology & Developmental Science in the College of Medicine. He has secured federal funding totaling over $1.3 million from the NIH/National Institute on Alcohol Abuse and Alcoholism for his work on FASD. His key collaborators are primarily within the University of Arkansas for Medical Sciences, including James C. Douglas, Cynthia J.M. Kane, Tonya Rafferty, and Kalee N. Holloway.

Research Overview

Drew Lab Research: Multiple Sclerosis Fetal Alcohol Spectrum Disorders Neuroimmunology Innate and Adaptive Immunity

Metrics

  • h-index: 39
  • Publications: 86
  • Citations: 4,733

Selected Publications

  • Early Postnatal Ethanol Exposure Has Long-Term Behavioral Consequences in Female Mice (2026)
    Cells DOI OpenAlex
  • Targeting the Nlrp3 inflammasome as potential treatment for ethanol-induced non-communicable diseases (2024)
    The American Journal of Drug and Alcohol Abuse DOI OpenAlex
  • Developmental Ethanol Exposure Impacts Purkinje Cells but Not Microglia in the Young Adult Cerebellum (2024)
    Cells 10 citations DOI OpenAlex
  • Ethanol Induces Neuroinflammation in a Chronic Plus Binge Mouse Model of Alcohol Use Disorder via TLR4 and MyD88-Dependent Signaling (2023)
    Cells 32 citations DOI OpenAlex
  • Developmental ethanol exposure has minimal impact on cerebellar microglial dynamics, morphology, and interactions with Purkinje cells during adolescence (2023)
    Frontiers in Neuroscience 11 citations DOI OpenAlex
  • Ethanol-induced cerebellar transcriptomic changes in a postnatal model of fetal alcohol spectrum disorders: Focus on disease onset (2023)
    Frontiers in Neuroscience 13 citations DOI OpenAlex
  • Cerebellar Transcriptomic Analysis in a Chronic plus Binge Mouse Model of Alcohol Use Disorder Demonstrates Ethanol-Induced Neuroinflammation and Altered Glial Gene Expression (2023)
    Cells 10 citations DOI OpenAlex
  • Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation (2022)
    The American Journal of Drug and Alcohol Abuse 16 citations DOI OpenAlex
  • Neuroimaging predictors of longitudinal disability and cognition outcomes in multiple sclerosis patients: A systematic review and meta-analysis (2021)
    Multiple Sclerosis and Related Disorders 12 citations DOI OpenAlex
  • Ethanol effects on cerebellar myelination in a postnatal mouse model of fetal alcohol spectrum disorders (2021)
    Alcohol 14 citations DOI OpenAlex
  • Ethanol modulation of hippocampal neuroinflammation, myelination, and neurodevelopment in a postnatal mouse model of fetal alcohol spectrum disorders (2021)
    Neurotoxicology and Teratology 15 citations DOI OpenAlex
  • Divergent and overlapping hippocampal and cerebellar transcriptome responses following developmental ethanol exposure during the secondary neurogenic period (2021)
    Alcoholism Clinical and Experimental Research 14 citations DOI OpenAlex
  • Microglia and astrocytes show limited, acute alterations in morphology and protein expression following a single developmental alcohol exposure (2021)
    Journal of Neuroscience Research 13 citations DOI OpenAlex
  • Ethanol modulation of cerebellar neuroinflammation in a postnatal mouse model of fetal alcohol spectrum disorders (2021)
    Journal of Neuroscience Research 26 citations DOI OpenAlex
  • Neuroinflammatory contribution of microglia and astrocytes in fetal alcohol spectrum disorders (2020)
    Journal of Neuroscience Research 60 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 3 $1,392,941 total

NIH Contact PI May 2026 - Jan 2031

Role of Oligodendrocyte-Lineage Cells in FASD

National Institute on Alcohol Abuse and Alcoholism $561,966 R01
NIH Contact PI Sep 2018 - Jun 2024

Dynamic neuroimmune interactions in the onset and progression of FASD

National Institute on Alcohol Abuse and Alcoholism $451,350 R01
NIH Contact PI Sep 2018 - Aug 2025

Neuroinflammation: Role in FASD Cognitive Deficits

National Institute on Alcohol Abuse and Alcoholism $379,625 R01

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • PPAR-alpha agonists as treatment for autoimmune demyelination National Multiple Sclerosis Society via The Ohio State University Research Foundation Principal Investigator
  • PPAR-Agonist as Treatment for Autoimmune Demyelination (Subcontract from UT Southwestern Medical Center) National Multiple Sclerosis Society via University of Texas - Southwestern Principal Investigator
  • LXR agonists as treatment for autoimmune demyelination National Multiple Sclerosis Society Principal Investigator
  • PPAR-gamma Immune Regulation and Multiple Sclerosis NIH Principal Investigator
  • Microglia modulate ethanol impact on CNS development. NIH Co-Investigator
  • Alcohol Pathogenesis in CNS Microglial Cells NIH Co-Investigator
  • Female Sex Steroids: Effects on Glia National Multiple Sclerosis Society Principal Investigator
  • Mechanisms of Ethanol-Induced Neuroinflammation and Neurodegeneration NIH Principal Investigator

Collaboration Network

24 Collaborators 5 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics